相关实验视频
Updated: Jul 12, 2025

08:43
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
7.4K
端粒维持机制亚型揭示了前置神经瘤中不同的免疫活性
Ji-Yong Sung1, Jung Woo Lee2,3
1Center for Genome Engineering, Institute for Basic Science, 55, Expo-ro, Yuseong-gu, Daejeon, 34126, Republic of Korea. 5rangepineapple@gmail.com.
Journal of neuro-oncology
|October 21, 2023
概括
带有高替代端粒延长 (ALT) 的静脉瘤患者的预后更好. 端粒维护机制影响免疫活动和患者的结果,建议个性化治疗.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 癌细胞的不朽性取决于端粒的维护.
- 端粒维持机制,包括端粒酶和替代端粒延长 (ALT),对于无限的细胞复制至关重要.
- 端粒酶和ALT在前庭神经瘤中的作用在很大程度上是未知的.
研究的目的:
- 为了研究端粒酶和ALT在前置神经瘤中的作用.
- 了解端粒维护对患者预后的影响.
- 探索前置性神经瘤中端粒维护和免疫活动之间的关系.
主要方法:
- 利用了基因组变异分析与散装和单细胞RNA测序.
- 根据端粒维护机制将前庭神经瘤患者分为亚型.
- 分析了与每个亚型相关的细胞和免疫特征.
主要成果:
- 具有较高ALT活性的患者的预后比具有较高端粒酶活性的患者更好.
- 高端粒酶组表现出抗原呈现细胞 (APC) 活性增加.
- 微质细胞,中性粒细胞和纤维细胞显示高端粒酶和APC活性;低ALT的施万细胞显示免疫活性升高.
结论:
- 端粒维护机制显著影响前庭神经瘤预后和免疫反应.
- 这些发现支持开发精准医学策略来治疗前庭神经瘤.
- 针对端粒维护和免疫通路的个性化药物疗法是有希望的.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Telomeres and Telomerase
23.4K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.4K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

